Unlocking The Potential of DEFA11P: A Protein with Unique Structure and Multiple Functions

Target Name: DEFA11P

NCBI ID: G724068

Other Name(s): DEFAP3 | Defensin alpha 11, pseudogene | defensin alpha 11, pseudogene

Unlocking The Potential of DEFA11P: A Protein with Unique Structure and Multiple Functions

DEFA11P (DEFAP3) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the superfamily of COOH-containing proteins, which are a type of transmembrane protein that can interact with a variety of molecules, including small molecules, ions, and hormones.

One of the unique features of DEFA11P is its structure. It has a unique topology, with a long extracellular tail that is involved in its interactions with other proteins and molecules. This tail is composed of a series of conserved domains, which are involved in the protein's stability and functions.

DEFA11P has been shown to play a variety of roles in various physiological processes in the body. For example, it has been shown to be involved in the regulation of cell signaling pathways, including the production of neurotransmitters such as dopamine and serotonin. It has also been shown to play a role in the regulation of inflammation, with studies showing that it can modulate the activity of immune cells and influence the production of pro-inflammatory cytokines.

In addition to its role in cellular signaling and inflammation, DEFA11P has also been shown to be involved in the regulation of sleep and wakefulness. Studies have shown that it is involved in the regulation of the circadian rhythm, which is responsible for controlling the production of hormones that regulate sleep and wakefulness.

Given its involvement in a variety of physiological processes, DEFA11P has potential as a drug target or biomarker. Studies have shown that inhibiting the activity of DEFA11P can have a variety of effects on various cellular processes, including the regulation of cell signaling pathways, the production of neurotransmitters, and the regulation of inflammation and sleep.

In addition to its potential as a drug target or biomarker, DEFA11P is also of interest as a potential therapeutic agent for a variety of disorders. For example, studies have shown that inhibiting the activity of DEFA11P can have neuroprotective effects, particularly in the context of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Overall, DEFA11P is a protein that has a unique structure and is involved in a variety of physiological processes in the body. Its potential as a drug target or biomarker, as well as its potential as a therapeutic agent for a variety of disorders, makes it an interesting and promising target for further research.

Protein Name: Defensin Alpha 11, Pseudogene

More Common Targets